Well, this is no good.This will end some of the speculation.But,...

Well, this is no good.
This will end some of the speculation.
But, this is good, because LC might smile, and that means positive news and selling for $50/share.
Can't wait. New speculation.
Oh, hang on, yes I can.
Did I ever tell you about the good professor at another company, who winked, nodded and said all good things are coming, 10 minutes before the share price went from $80 to $4.
Yep. This is a real chart. Imagine the ones who bought in at the top and lost 95%, waiting, hoping for it to turn around.
But just so you know, this also had a product that took it from mere cents to near $20, then consolidate, then the product failed, back to $4.
Then, a new product, and now over $20, commanding CR's literally at market price. Something IMU needs to learn how to do.
Kind of a bit like having a cents company, then her-vaxx, then 60 cents, then failed (sort of), back to 5 cents, and then, well, you know where are are now.
But, did the original IMU product fail, or is it actually saleable, so similar, but not the same.
Is the new IMU product in its infancy but looking positive. I think so.
So the drop in this chart, is the original product failure to market, and not the current product, and it looks like IMU chart. But not the same as IMU can still deal with the original product, where this other company, just walked away, never to hear from the professor again. That's something you don't want.
Isn't there a presentation this week.
Thursday April 18th at the 2024 Cholangiocarcinoma Foundation Annual Conference. The actual presentation where they were selected to speak.